RSS-Feed abonnieren
DOI: 10.1055/s-0040-1720865
Atropisomeric Properties of 9-Methyl-1,4-benzodiazepin-2-ones
This work was supported in part by a Grant-in-Aid for Scientific Research (C) (19K06980) from the Japan Society for the Promotion of Science. H.T. is grateful for financial support from the Hoansha Foundation.
![](https://www.thieme-connect.de/media/synthesis/202124/lookinside/thumbnails/ss-2021-f0374-op_10-1055_s-0040-1720865-1.jpg)
Abstract
The atropisomeric and conformational properties of 1,4-benzodiazepin-2-ones were investigated by freezing the conformation with a methyl group at the C9 of 1,4-benzodiazepine. It was revealed that 1,4-benzodiazepin-2-ones exist only as a pair of enantiomers [(a1 R, a2 S) and (a1 S, a2 R)], which was confirmed by X-ray analysis. The absolute configuration of each atropisomer was deduced by comparing the [α]D and CD data with those of (–)-N-methoxycarbonylmethylated 9-methyl-5-phenyl-1,4-benzodiaepin-2-one derivative. It was elucidated that the corresponding N-methylated derivative showed similar CD spectra, although the rotational direction of [α]D was opposite to that of others.
Key words
atropisomerism - absolute configuration - 1,4-benzodiazepin-2-one - CD spectra - X-ray crystal structure analysisSupporting Information
- Supporting information for this article is available online at https://doi.org/10.1055/s-0040-1720865.
- Supporting Information
Publikationsverlauf
Eingereicht: 28. Juni 2021
Angenommen nach Revision: 26. Juli 2021
Artikel online veröffentlicht:
27. August 2021
© 2021. Thieme. All rights reserved
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1a Ryan JH, Hyland C, Meyer AG, Smith JA, Yin JX. Prog. Heterocycl. Chem. 2012; 24: 493
- 1b Ramig K. Tetrahedron 2013; 69: 10783
- 2a Natsugari H, Ikeura Y, Kamo I, Ishimaru T, Ishichi Y, Fujishima A, Tanaka T, Kasahara F, Kawada M, Doi T. J. Med. Chem. 1999; 42: 3982
- 2b Tabata H, Nakagomi J, Morizono D, Oshitari T, Takahashi H, Natsugari H. Angew. Chem. Int. Ed. 2011; 50: 3075
- 2c Tabata H, Wada N, Takada Y, Nakagomi J, Miike T, Shirahase H, Oshitari T, Takahashi H, Natsugari H. Chem. Eur. J. 2012; 18: 1572
- 2d Yoneda T, Tabata H, Tasaka T, Oshitari T, Takahashi H, Natsugari H. J. Med. Chem. 2015; 58: 3268
- 2e Tabata H, Yoneda T, Oshitari T, Takahashi H, Natsugari H. J. Med. Chem. 2017; 60: 4503
- 3 Lee S, Kamide T, Tabata H, Takahashi H, Shiro M, Natsugari H. Bioorg. Med. Chem. 2008; 16: 9519
- 4 Sugasawa T, Toyoda T, Adachi M, Sasakura K. J. Am. Chem. Soc. 1978; 100: 4842
- 5 Sugasawa T, Adachi M, Sasakura K. J. Heterocycl. Chem. 1979; 16: 445
-
6 CCDC 2089341 (6a-II), CCDC 2089142 (6c-II), CCDC 2088860 [(–)-6b-I], CCDC 2088861 [(–)-6b-II] contain the supplementary crystallographic data for this paper. The data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/structures.
- 7 Feng Y.-S, Ma J.-J, Kang Y.-M, Xu H.-J. Tetrahedron 2014; 70: 6100